Status:
COMPLETED
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also hel...
Detailed Description
OBJECTIVES: Primary * Determine gene expression, genome integrity, cytosine methylation, and chromatin structure in patients with normal cytogenetics leukemia (NCL) acute myeloid leukemia. * Determi...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of acute myeloid leukemia
- Enrolled on clinical trial ECOG-E1900
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
March 23 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2009
Estimated Enrollment :
418 Patients enrolled
Trial Details
Trial ID
NCT00897936
Start Date
March 23 2006
End Date
October 15 2009
Last Update
July 31 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.